Cargando…
Sequential administration of anti-PD-1 and anti-Tim-3 combined with an SA-GM-CSF-anchored vaccine overcomes adaptive immune resistance to reject established bladder cancer
Program death receptor-1 (PD-1) and T-cell immunoglobulin and mucin domain-containing protein-3 (Tim-3) play an important role in tumor immune evasion. PD-1 blockade could produce an effective anti-tumor effect but the response rate was low due to lacking of tumor infiltrating lymphocytes (TILs) and...
Autores principales: | Zhang, Xinji, Liu, Guang, Shi, Xianghua, Shi, Xiaojun, Li, Jinlong, Mo, Lijun, Gao, Jimin, Long, Zhaolin, Tan, Wanlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974521/ https://www.ncbi.nlm.nih.gov/pubmed/33753998 http://dx.doi.org/10.7150/jca.44769 |
Ejemplares similares
-
PD-1 Blockade Overcomes Adaptive Immune Resistance in Treatment with Anchored-GM-CSF Bladder Cancer Cells Vaccine
por: Zhang, Xinji, et al.
Publicado: (2018) -
Increased Tim-3 expression on TILs during treatment with the Anchored GM-CSF vaccine and anti-PD-1 antibodies is inversely correlated with response in prostate cancer
por: Zhang, Xinji, et al.
Publicado: (2020) -
Norcantharidin enhances antitumor immunity of GM‐CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells
por: Mo, Lijun, et al.
Publicado: (2018) -
The pilot-scale preparation of the SA-hGM-CSF bi-functional fusion protein
por: Li, Xiaoqing, et al.
Publicado: (2019) -
A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF
por: Hu, Zhiming, et al.
Publicado: (2010)